Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
262728293031 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Methamphetamine and the Heart: Combating Heart Disease on the Islands

Catasys Health - Friday, December 17, 2010

By Paige L. Jinbo
As heart disease continues to be the No. 1 cause of death in Hawaii, it’s critical that the state’s hospitals are staffed enough trained cardiologists — 109 to be exact. However, research provided by the John A. Burns School of Medicine has shown that Hawaii only has 62 trained cardiologists, 47 short of what’s deemed sufficient.
 » More


Drug Seeking Behavior in ER Doubles

Catasys Health - Thursday, October 28, 2010

Drug Seeking Behavior in ER Doubles, Feeds Growing Addiction to Pain Pills -- Emergency rooms continue to become a major resource for pain medication addicts; By MIKAELA CONLEY, ABC News Medical Unit -- Oct. 28, 2010 » More


8 Drivers Impacting Cost Savings

Catasys Health - Thursday, September 23, 2010

Catasys On Healthcare September 2010 Newsletter
This edition of the Catasys newsletter outlines 8 drivers impacting cost savings from your substance dependent population. Surprisingly, national averages show $160 million in claims are incurred by substance dependent members in a 1 million member health plan. The majority of these costs are medical, driven by the consequences of substance abuse (and are mitigated if the substance abuse is successfully addressed).  » More


Catasys Launches OnTrak™ Facebook Page

Catasys Health - Monday, January 04, 2010
Check out our new Catasys Health Facebook Recovery Network http://www.facebook.com/stayontrak. Also, don't forget to Like our Facebook Health Care Page.

Social Media Philosophy - Lead the social media revolution in Substance Dependence and Behavioral Health Care, contributing to health and well being for families and friends everywhere.

 » More

Cutting Edge Treatment for Substance Dependence for Health Plans

Catasys Health - Wednesday, December 16, 2009
For every 1 million members in a health plan, approximately $160 million in claims are incurred by members diagnosed with Substance Dependence. Most health plans have realistic cost savings opportunities in the millions of dollars. Our Medical Economics group can demonstrate specific savings opportunities for health plans with respect to both medical and behavioral costs.

The OnTrak program addresses many of the challenges experts highlight within the existing treatment paradigm for substance dependence. Specifically, OnTrak» More

Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Flumazenil and Gabapentin in Reducing Craving and Use During use during Initial Treatment of Methamphetamine Dependence

Catasys Health - Wednesday, November 25, 2009

Harold Urschel, Research Across America, Dallas, Texas
Published in the Journal of Psychopharmacology, November 25, 2009
 » More




| 1 2 | Next

 

 
  Tags
 
craving score methadone UnitedHealthcare gabapentin smoking overdose double-blind hydrocodone trauma substance dependence health insurance craving opiates Opioid Treatment Journal of Psychopharmacology Opioid Medications morphine sober behavioral health pain medication ADD substance dependence costs relapse prevention social network bipolar disorder Opioid Prescribing alcohol drug abuse PTSD addiction treatment depression screening opiod-based medical medical costs diabetes buprenorphine heroin naloxone stimulants contract opiod abuse stratified alcohol drinking mental health binge drinking behavioral health care alcoholism marijuana SD health insurance mental illness cigarettes over-the-counter substances randomized opioid overdose narcotic Raymond Anton meth high-utilizing recovery drinking identification psychosocial Co Occurring Disorders prometa OxyContin drug use drug addicts health plan codeine muscle relaxant addiction pain killers vivitrol physician- patient relations treatment placebo-controlled Catasys flumazenil prescriptions post-traumatic stress disorder substance dependence substance use disorder behavioral healthcare opioid-drug interactions drug overdose data mining depression behavioral health care services oxycodone opioid sugar percocet CIWA reduction in use alcohol dependence suboxone Health Care Utilization relapse dependence issues nicotine methamphetamine dependence painkillers withdrawal drug addiction health reform emergency room primary care care coaching pain pills reduction in craving Harold Urschel SD members fentanyl opioid antagonist urine drug screen recovery network Research Across America sobriety predictive modeling methamphetamine hospitalizations vicodin cocaine treatment placebo drug treatment addict reducing craving ER health insurance hospital anxiety stress alcohol treatment chronic pain medical and behavioral costs behavioral healthcare services communication opioid abuse ADHD OnTrak cocaine facebook
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414